Skip to content

Internet Based Cognitive Behavior Treatment for Alcohol Problems

Internet Based Cognitive Behavior Treatment for Alcohol Problems: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02384278
Acronym
ICBT-AP
Enrollment
13
Registered
2015-03-10
Start date
2015-03-31
Completion date
2017-07-31
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorders

Keywords

alcohol use disorder, internet, cognitive behavior therapy, relapse prevention

Brief summary

The purpose of this study is to determine whether internet based cognitive behavior therapy might be effective in the treatment of alcohol problems.

Detailed description

A 12 week Internet based self help program based on cognitive behavioral therapy and relapse prevention is tested among Internet help seekers as well as among patients seeking help in addiction care.The design is a one armed pilot study, and outcomes are measured in terms of changes in alcohol consumption, problematic alcohol use, self efficacy, craving, as well as depression and quality of life. 20 participants are recruited entirely online from an open access website and 20 participants are recruited through information given to them at an addiction clinic. All participants have access to the same self help program and have access to a licensed psychologist who guides the person all the way through the program.

Interventions

BEHAVIORALInternet-based CBT for alcohol problems

A 12-week internet-based program based on cognitive behavior treatment (CBT) and relapse prevention

Sponsors

Göteborg University
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years * access to the Internet * problematic alcohol use defined as ≥ 16 p or more for men and ≥ 14 p or more for women in the Alcohol Use Identification Scale

Exclusion criteria

* not adequately fluent in Swedish * reading or writing impairment if this is so severe as to affect treatment * ongoing psychological treatment with content similar to the treatment being studied * suicide risk defined as ≥ 4 p på MADRS-S Q 9 or through a telephone interview with clinician * severe depression defined as MADRS-S ≥ 30 p * somatic or psychiatric conditions that are contraindicated for the treatment such as psychosis, bipolar disorder (depressive or manic phase), severe post traumatic stress disorder. * has during the last 3 weeks begun using medication for alcohol problems or other psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Time Line Follow Back (TLFB)Baseline, 14 and 26 weeksChange in total TLFB score (consumption during preceding week), as a summarized

Secondary

MeasureTime frameDescription
Drug Use Identification Test (DUDIT)Baseline, 14 and 26 weeksChange in total DUDIT score, as a summarized measure of drug use (including drug consumption and drug-related problems)
Montgomery Asberg Depression Rating Scale - self report (MADRS-S)Baseline, 14 and 26 weeksChange in total MADRS-S score, as a summarized measure of depression
World Health Organization Quality of Life Scale (WHOQOL-BREF)Baseline, 14 and 26 weeksChange in total WHOQOL-BREF score, as a summarized measure of quality of life
Alcohol Use Disorders Identification Test (AUDIT)Baseline, 14 and 26 weeksChange in total AUDIT score, as a summarized measure of alcohol use (including alcohol consumption and alcohol-related problems)
Penn Alcohol Craving Scale (PACS)Baseline, 14 and 26 weeks
Readiness to Change Questionnaire (RTCQ)Baseline, 14 and 26 weeksScore in RTCQ as a summarized measure of motivation used as predictor for other outcomes
Alcohol Abstinence Self Efficacy Scale (AASES)Baseline, 14 and 26 weeksChange in total AASES score, as a summarized measure of self efficacy

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026